5 pharmaceutical companies were revoked GSP certificate!

At the peak of the storm, another 5 pharmaceutical companies committed crimes against the wind and hit the muzzle of the gun! Yesterday, five pharmaceutical enterprises, including Anhui Xinsheng Pharmaceutical Co., Ltd., Fujian Huayao Pharmaceutical Co., Ltd and Xiamen Hanfeng Pharmaceutical Co., Ltd., were revoked the GSP certificate by the local food and drug administration due to their violation of the provisions of the "Regulations on the quality management of pharmaceutical trading" The details are as follows: 1 Anhui food and Drug Administration issued an advertisement to revoke Anhui Xinsheng Pharmaceutical Co., Ltd (formerly Anhui Luyan Dahua Pharmaceutical Co., Ltd.) drug GSP certificate Anhui Xinsheng Pharmaceutical Co., Ltd (the former Anhui Luyan Dahua Pharmaceutical Co., Ltd.) has seriously violated the provisions of the "quality management standards for pharmaceutical trading", in accordance with the provisions of Article 45 of the "measures for the administration of the quality management standards for pharmaceutical trading" issued by the former State Food and drug administration and the "certificate of the Anhui food and Drug Administration on the standardization of the quality management standards for pharmaceutical trading" According to the requirements of the notice on the cancellation of the Act (wsyjychl [2016] No 134), our bureau has cancelled its certificate of quality management standard for drug distribution in accordance with the law, which is hereby promulgated 2、 Fujian food and Drug Administration issued an advertisement and took back the certificate of quality management standard for drug distribution issued by Fujian Huayao Pharmaceutical Co., Ltd and Xiamen Hanfeng Pharmaceutical Co., Ltd In accordance with the quality management specifications for drug distribution (Order No 13 of the General Administration), the measures for the administration of the certification of the quality management specifications for drug distribution and the measures for the flight inspection of pharmaceutical and medical devices (Order No 14 of the General Administration), due to the violation of the relevant provisions of the quality management specifications for drug distribution by enterprises, our bureau has withdrawn the certificate of the quality management specifications for drug distribution issued by Fujian Huayao Pharmaceutical Co., Ltd 》(Certificate No.: fj04-aa-20140115) and Xiamen Hanfeng Pharmaceutical Co., Ltd (Certificate No.: fj02-aa-20140039) are hereby announced 3、 Sichuan food and Drug Administration revoked the drug business license of Chengdu renbang Pharmaceutical Co., Ltd and Chengdu Luyan Guangfu Pharmaceutical Co., Ltd Luyan Pharmaceutical (002788), a listed company that was previously exposed to be involved in the vaccine case in Shandong Province, announced in the evening of April 20 that its two subsidiaries had been revoked the drug business license by the Sichuan food and drug administration due to the fictitious flow of vaccine sales According to the announcement, on April 20, Chengdu renbang Pharmaceutical Co., Ltd and Chengdu Luyan Guangfu Pharmaceutical Co., Ltd., the subsidiaries of Luyan pharmaceutical Holding Co., Ltd., respectively received the notice of administrative penalty from Chengdu food and drug administration Renbang Pharmaceutical Co., Ltd made up the sales flow of two drugs (vaccines) (the total sales amount is 655900 yuan), while Luyan Guangfu Pharmaceutical Co., Ltd made up the sales flow of three drugs (vaccines) (the total sales amount is 492000 yuan), which has become illegal.